Safety and immunogenicity of an experimental live combination vaccine against enterovirus 71 and coxsackievirus A16 in rhesus monkeys
- 11 March 2020
- journal article
- research article
- Published by Taylor & Francis Ltd in Human Vaccines & Immunotherapeutics
- Vol. 16 (7), 1586-1594
- https://doi.org/10.1080/21645515.2019.1709353
Abstract
Enterovirus 71 (EV-A71) and Coxsackievirus A16 (CV-A16) are the two most common pathogens causing hand, foot, and mouth disease (HFMD). Previously, we obtained one candidate live attenuated strain each for EV-A71 and CV-A16; here, we evaluated the safety and immunogenicity of a combinedlive vaccine against EV-A71 and CV-A16 generated from these two candidate strains. Rhesus monkeys were intramuscularly treated with a live combinationvaccine against both EV-A71 and CV-A16 or with either vaccine alone. No fever or atypical clinical signs were observed in any animals. Monkeys vaccinated with the combinationlive vaccine presented no notable pathological changes in the brain, spinal cord, lung, and liver; in contrast, these regions showed inflammatory cell infiltration in monkeys treated with EV-A71 alone or CV-A16 alone. Weak viremia was detected in plasma after inoculation with the combinationvaccine; however, the duration of viral shedding in feces was increased. Biochemical studies revealed a slight increase in aspartate aminotransferase levels in monkeys inoculated with the live combination vaccine; however, histopathological findings did not attribute this change to liver damage. We also found that the live combinationvaccine induced a dual humoral immune response. Cytokine analysis indicated that the combined EV-A71/CV-A16 vaccine significantly down-regulated interleukin-8 production. Here, we have demonstrated that the live attenuated EV-A71/CV-A16 vaccine was safe and could trigger a dual specific immune response. However, its immune protection efficacy requires further investigation.Keywords
Funding Information
- CAMS Innovation Fund for Medical Sciences (2016-I2M-1-019)
- Yunnan Applied Basic Research Projects (2015BC008)
- PUMC Youth Fund (3332019110)
This publication has 22 references indexed in Scilit:
- Immunogenicity and Safety of an F-Genotype Attenuated Mumps Vaccine in Healthy 8- to 24-Month-Old ChildrenThe Journal of Infectious Diseases, 2018
- Effects of gamma radiation on microbial, physicochemical, and structural properties of whey protein model systemJournal of Dairy Science, 2018
- A comparative study of multiple clinical enterovirus 71 isolates and evaluation of cross protection of inactivated vaccine strain FY-23 K-B in vitroVirology Journal, 2017
- Pathologic and immunologic characteristics of coxsackievirus A16 infection in rhesus macaquesVirology, 2016
- Similar protective immunity induced by an inactivated enterovirus 71 (EV71) vaccine in neonatal rhesus macaques and childrenVaccine, 2015
- Target Spot on Menispermum dauricum Caused by Streptobotrys (≡Streptotinia) caulophylli, a New Disease in ChinaPlant Disease, 2014
- An Inactivated Enterovirus 71 Vaccine in Healthy ChildrenThe New England Journal of Medicine, 2014
- Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialThe Lancet, 2013
- Safety and immunogenicity of a novel human Enterovirus 71 (EV71) vaccine: A randomized, placebo-controlled, double-blind, Phase I clinical trialVaccine, 2012
- Primary Study of Attenuated Live Hepatitis A Vaccine (H2 Strain) in HumansThe Journal of Infectious Diseases, 1989